Case Number:

PGR2019-00048

Case Type:

PGR

Status:

FWD Entered

Petitioner:

Teva Pharmaceuticals USA, Inc.

1. Filed: May 07, 2019 00:00

   Coverage

   1. November 21, 2019

      Teva Gets PTAB To Review Cushing's Syndrome Drug Patent

      The Patent Trial and Appeal Board will look at whether a patent covering Corcept Therapeutics Inc.'s flagship Cushing's syndrome medication Korlym is invalid, following a challenge from Teva Pharmaceuticals USA Inc.

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login